Medicenna to Present MDNA19 Pre-clinical Update at the 5th Annual International Cancer Immunotherapy Conference

Title:

Long-acting MDNA109: Emerging IL-2 Superkines displaying potent anti-tumoral responses.

Presenter:

Dr. Minh To, Ph.D.

Poster #:

B042  

Date/Time:

Friday, September 27^th, 2019 from 1:00-3:00pm and 6:30-8:00pm

Location:

Espace Grande Arche, Tunnel de Nanterre-La Défense, 92044 Paris La Défense, France